Fezolinetant

CAS : 1629229-37-3

Ref. 3D-EQC22937

Informations sur le produit

• Nom: Fezolinetant
• Marque: Biosynth
• Description: Fezolinetant is a drug for the treatment of menopausal symptoms. It is designed to be administered as a single dose, with the primary analysis being a questionnaire on the frequency and severity of symptoms. Fezolinetant has been shown to be efficacious in treating autoimmune diseases, such as rheumatoid arthritis and systemic lupus erythematosus. Fezolinetant also prevents cancer in mice by inhibiting the invasion and migration of tumor cells. The drug binds to receptors in cells that are involved in cancer cell growth and proliferation, which blocks the production of proteins that are essential for tumor cell division. This drug also has an efficient method of delivery, which may reduce side effects.

Propriétés chimiques

• Masse moléculaire: 358.39 g/mol
• Formule: C₁₆H₁₅FN₆OS
• Degré de pureté: Min. 95%